I am sorry that it has taken me a little longer than usual to get back to you with a decision on your manuscript. We have received the last referee report only yesterday! As you will see, all referees are extremely positive about the suitability of the study for publication in EMBO reports, although referees 2 and 3 have for minor concerns that should be addressed. Of special importance is making the data in Fig. 3B on the pupylation of E. coli proteins in Mtb more conclusive (as requested by referees 2 and 3), and further characterizing the new site of FabD pupylation (Fig. 1B) to rule out the possibility of proteolysis.
In addition, referees 2 and 3 also ask that a number of minor technical issues be addressed, which would make the study more accessible to a general reader. As you will see, all of the referees also mention that different parts of the text should be made more accurate and precise, so please carefully go through the manuscript (including text, figures and tables) in this regard. Please also merge the Results and Discussion sections, which is more appropriate for a short format and will allow you to eliminate some redundancy inherent to presenting them separately. As you have only three figures, after carefully editing the manuscript, you will not need to shorten it further (the text can be longer than normal, as we usually have up to 5 figures). You will even have space to briefly describe the depupylase assay and include a table in the main text with the pupylated E. coli proteins, as requested! After these concerns have been adequately addressed, we will be happy to accept your work for publication in EMBO reports. Please note that revised manuscripts must be submitted within three months of a request for revision; they will otherwise be treated as new submissions. The manuscript under consideration describes the development of a powerful new tool to investigate the mechanism of pupylation by reconstituting the Mycobacterium modification machinery in E. coli. There are two benefits to this. First E. coli is much better developed as a model organism and allows much more convenient manipulation than Mycobacterium. Second, E. coli does not contain a native pupylation system, which makes it possible to dissect the mechanism of this tagging system by adding and manipulating components and comparing the results to the native process in Mycobacterium. For example, the manuscript describes some proteins that are pupylated by the machinery in E. coli but not in Mycobacterium, which now makes it possible to investigate the basis of these differences.
The experiments are well conceived and described. I have no concerns about the technical quality of the work.
Overall the manuscript is well written and argued. Still at times is the writing feels a little rushed, which together with some jargon and imprecision of expression, is somewhat distracting. These issued should be easily resolved by some editing.
Referee #2:
This interesting manuscript by Cerda-Maira et al. presents the findings of a study of the pupylation range of proteins using Escherichia coli as a heterologous host. Pupylation is a mechanism used by actinobacteria to address proteins to the proteasome for degradation and it involves attachment of Pup, a 63 amino-acid long peptide, to lysine residues in the target protein. There are certain similarities to the ubiquitination process mediated by ubiquitin ligases in eukaryotes. The aim of the present study was to assess the specificity of the Pup system by expressing the mycobacterial enzymes involved in E. coli, a host lacking this system, together with known mycobacterial substrates, FabD and Ino1. While this approach was successful, confirming the roles of PafA, Dop and Pup, it also revealed that no other mycobacterial functions were required and that heterologous substrates, namely >53 E. coli proteins, were also pupylated. Some of these heterologous substrates were then expressed in mycobacteria and their pupylation monitored there. These are important findings for understanding the principles of protein degradation.
Overall, the paper is easy to follow and the findings are convincing but the following points merit consideration:
1. On p.5, reference is made to lane numbers in Fig 1 but no such numbers are present in the figure.
2. The authors examine the effect of pupylation on mycobacterial FabD in pupylation-competent E. coli and use a K173A variant to probe Pup substrate specificity since K173 is the normal site of pupylation. This results in a reduction in the intensity of the 48 kDA Pup-FabD species but not in its complete disappearance, which might have been expected if K173 were the sole site of pupylation. A second, slightly smaller species is seen and this appears to be more abundant than when wild type FabD was used. The authors should state the size of this second species (there are no molecular weights indicated in Fig. 1B ). It is also highly desirable to explain this difference in size by performing mass spectrometric analysis of the two species and to localize the new site of pupylation 5. Also on p.8, it is stated "However, it is also possible that these larger species are different pupylated proteins that co-purified with Adk-His6." If this is the case then it is readily testable by performing the Western blot experiment with antibodies to Pup. As it stands, it is just as likely that these are histidine-rich proteins that copurified with his-tagged Adk and were recognized by the His5-antibody.
6. On p.10, I don't understand this statement "We therefore speculate that the "specificity" of pupylation in mycobacteria may be in its prevention." Please expand.
7. On p.10, "The second surprise was the observation that numerous E. coli proteins could also be pupylated, and at least one could be pupylated in mycobacteria." Please specify which one.
8. On p.11, I don't understand this statement "Thus protein modifiers do not always require a specific signal, and may rely on "mass action" to find their targets." Please clarify "mass".
9. On p.13, "peptide level to using the target-decoy strategy" needs attention. Overall, the authors present an exciting study that furthers our understanding of pupylation, a mechanism of protein-conjugation that was recently discovered in mycobacterium by this group. The researchers provide important findings on how this system can be expressed and can function in recombinant E. coli with minimal components from mycobacterium.
Comments: 1. The title is misleading and suggests that E. coli has a pupylation system. Instead, the paper describes synthesis and analysis of the mycobacterial pupylation system in recombinant E. coli. Highly recommend modifying the title to avoid this confusion.
2. The last sentence of the abstract seems a little too strong. Based on the data provided, one could still argue that pupylation requires specific co-factors for native substrate recognition and that the recombinant E. coli system with Pup-Glu and PafA is expressed at a much higher level than would occur in a normal organism. Thus, you have a recombinant system that is relatively unregulated (esp. since deamination is no longer required) and pupylates nearly everything (with exception of the mycobacterial DlaT which may be aggregated and inaccessible for pupylation in the modified E. coli strain).
Minor comments/questions: p3 ln 1-9: The introductory paragraph would confuse a general scientific audience e.g., it is unclear what you mean by protein-to-protein; is ubiquitin a protein-modifier? etc. Also avoid citing reviews written by oneself for key studies (e.g., p 3 ln 6 Darwin and Hofmann, 2010). p4 ln 16: At the beginning of the results section, please define the substrates that have been demonstrated to be pupylated in vitro for clarity. p5 ln 5: Please clarify earlier in this section that DlaT is a mycobacterial protein that is not pupylated. Defining all of the nomenclature in Fig. 1A will facilitate the ability of others to interpret the first sentence of this paragraph which refers to Fig. 1A . p6 ln 7-9: The general statement, that describes how polypupylated FabD has not been observed in any system, has no qualifiers (e.g., a citation or data on the conditions used to monitor and detect this lack of polypupylation). Without this type of information, the sentence becomes overly general and can lead to the field accepting assumptions. P7 ln 15+: E. coli pupylome, this phrase is misleading since it is a recombinant system. Please clarify at the beginning of this section that the E. coli strain used for this analysis was expressing the mycobacterial PupGln and PafA. P8 paragraph 2 ( Fig. 3B and associated text): The theme sentence of this paragraph is misleading since it describes monitoring the pupylation of E. coli PtsI-His and Adk-His in the recombinant E. coli system (+PafA +Pup-Glu). Probing the cell lysate or a Ni2+-chromatographic fraction of E. coli expressing the His-tagged substrate proteins with anti-His5 antibody is not convincing me that the proteins detected on this blot are pupylated (esp. without a negative control). The low signal of the 77kDa band claimed to be the Pup-PtsI is a problem, since bands of similar migration are observed in the left lane of the second blot and right lane of the third blot of Fig 3B. A negative control is needed (e.g., an E. coli strain +PafA +Pup-Glu that is not expressing a protein target) to claim that these bands are specific for the target substrate. Analysis of cell lysate (including the negative control) by Ni2+-chromatography followed by immunoblot with anti-Pup antibody would enable one to: i) determine the background of 'non-specific' pupylated proteins that co-purify in the Ni2+-chromatography step and ii) provide more convincing evidence that the His-tagged protein is pupylated compared to analysis with anti-His antibody. Please note Fig. 3B is meant (vs. Fig. 4B as stated).
Out of reader interest, you may want to briefly state (e.g. OD 600) what happens when E. coli expresses this highly active pupylation system? Do the cells still grow after addition of IPTG? or is growth arrested compared to similar constructs expressing the mycobacterial proteins with sitedirected mutations? (Burns et al., 2010) for the depupylation assay, some key details on the assay used in this study (e.g. ug substrate, ug Dop, concentration of nucleotides) would be assist in interpreting Fig. 3A (esp. since the pupylome of recombinant E. coli was not used as a substrate for the paper cited). Table S1 : relevant genotype for plasmids seems more like a mixture of genotype and other information. Table S3 and Table S4 were not carefully prepared. Please add a title to these figures, indicate the table numbers, and define UPSP and other information used in the tables. We have added lane numbers to Fig. 1A .
The authors examine the effect of pupylation on mycobacterial FabD in pupylationcompetent E. coli and use a K173A variant to probe Pup substrate specificity since K173 is the normal site of pupylation. This results in a reduction in the intensity of the 48 kDA PupFabD species but not in its complete disappearance, which might have been expected if K173 were the sole site of pupylation. A second, slightly smaller species is seen and this appears to be more abundant than when wild type FabD was used. The authors should state the size of this second species (there are no molecular weights indicated in Fig. 1B). It is also highly desirable to explain this difference in size by performing mass spectrometric analysis of the two species and to localize the new site of pupylation in the smaller protein. This would provide more convincing proof and rule out the possibility of proteolysis.
We have now purified the two bands and indeed identified at least 3 modified lysines: K122, K173 and K181. This is now described in the text and Fig. 1B .
It would be helpful to the average reader to give some examples of the 53 pupylated E. coli proteins in the main text rather than in the supplementary materials.
We have moved the former Fig. 4 . There is no Fig. 4 , this should be Fig. 3 . The Referee is correct and we have changed "4" to "3".
Also on p.8, it is stated "However, it is also possible that these larger species are different pupylated proteins that co-purified with Adk-His6." If this is the case then it is readily testable by performing the Western blot experiment with antibodies to Pup. As it stands, it is just as likely that these are histidine-rich proteins that copurified with his-tagged Adk and were recognized by the His5-antibody.
To clarify: these larger species were indeed observed with antibodies to Pup as indicated below the blot in Fig. 3 , thus our hypothesis was that these larger species could be E. coli proteins that were pupylated and co-purified with Adk if they are not themselves pupylated Adk. If they were histidine-rich as suggested by the Referee, they would have also purified from the control sample. We have made a revised Fig. 3 that should clarify this concern (also see our last response to Referee 3).
On p.10, I don't understand this statement "We therefore speculate that the "specificity" of pupylation in mycobacteria may be in its prevention." Please expand.
We have better explained this in the Results and Discussion. 7. On p.10, "The second surprise was the observation that numerous E. coli proteins could also be pupylated, and at least one could be pupylated in mycobacteria." Please specify which one.
We have now specified "PtsI" in this statement. 8. On p.11, I don't understand this statement "Thus protein modifiers do not always require a specific signal, and may rely on "mass action" to find their targets." Please clarify "mass". We more clearly explained this statement in the Results and Discussion. 9. On p.13, "peptide level to using the target-decoy strategy" needs attention. We have changed the title to address the Referee's comment. 2. The last sentence of the abstract seems a little too strong. Based on the data provided, one could still argue that pupylation requires specific co-factors for native substrate recognition and that the recombinant E. coli system with Pup-Glu and PafA is expressed at a much higher level than would occur in a normal organism. Thus, you have a recombinant system that is relatively unregulated (esp. since deamination is no longer required) and pupylates nearly everything (with exception of the mycobacterial DlaT which may be aggregated and inaccessible for pupylation in the modified E. coli strain Fig. 2B . Under the conditions tested, pupylation does not appear to be toxic to E. coli. Fig. 1A , what antibody was used for the top blot etc) ? It was anti-FabD, which has now been noted in the Fig. 1A . Fig. 1C , a vector control is needed for this blot to identify the non-specific bands observed with the anti-Ino1 antibody. We actually had already done a better control: we used all identical plasmids except Pup had Gln at the C-term in the control lane. Fig. 2E , please fully clarify in the figure legend the symbols that are used above this last blot of Fig. 2 Table S1 and described in detail elsewhere. "comp" was defined in the legend and in Table S1 . The plasmid is also described in Table S1 . Fig. 3A : Although the authors cite (Burns et al., 2010) I have now heard back from referees 2 and 3, to whom I sent the revised version of your manuscript. I am happy to say that they are both fully supportive of the study. Thus, I am happy to say that your study will be accepted for publication, pending a few formal issues.
I am happy to be the bearer of good news! I look forward to receiving your final manuscript file and figure 3.
Yours sincerely, Editor EMBO reports ----------
Referee comments
Referee #2:
